Cancer in patients on chronic dialysis in Korea

Journal of Korean Medical Science

Volumn 24, Issue SUPPL.1, 2009, Pages

  Lee, Jung Eun ^a   Han, Seung Hyeok ^a   Cho, Byoung Chul ^a   Park, Jung Tak ^a   Yoo, Tae Hyun ^a   Kim, Beom Seok ^a   Park, Hyeong Cheon ^a   Kang, Shin Wook ^a   Lee, Ho Yung ^a   Han, Dae Suk ^a   Ha, Sung Kyu ^a   Choi, Kyu Hun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Chronic; Gastrointestinal tract; Kidney failure; Neoplasms; Urinary tract

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; KOREA; MALE; MIDDLE AGED; NEOPLASM; PERITONEAL DIALYSIS; REGISTER; RENAL REPLACEMENT THERAPY; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KOREA; MALE; MIDDLE AGED; NEOPLASMS; PERITONEAL DIALYSIS; REGISTRIES; RENAL DIALYSIS; TIME FACTORS;

EID: 62449266345     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.S1.S95     Document Type: Article

References (33)

1. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-62.
2. Lameire N, Bernaert P, Lambert MC, Vijt D. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1994; 48 (Suppl): S31-8.
3. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 1994: 99-109.
4. Brunner FP, Landais P, Selwood NH. Malignancies after renal transplantation: the EDTA-ERA registry experience: European Dialysis and Transplantation Association-European Renal Association. Nephrol Dial Transplant 1995; 10 (Suppl 1): 74-80.
5. Pecqueux JC, Schwarz A, Dieckmann KP, Offermann G. Cancer incidence in patients on chronic dialysis and in renal transplant recipients. Urol Int 1990; 45: 290-2.
6. Sheil AG, Flavel S, Disney AP, Mathew TH. Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc 1985; 17: 1685-8.
7. Matas AJ, Simmons RL, Kjellstrand CM, Buselmeier TJ, Najarian JS. Increased incidence of malignancy during chronic renal failure. Lancet 1975; 1: 883-6.
8. Kinlen LJ, Eastwood JB, Kerr DN, Moorhead JF, Oliver DO, Robinson BH, de Wardener HE, Wing AJ. Cancer in patients receiving dialysis. Br Med J 1980; 280: 1401-3.
9. Ota K, Yamashita N, Suzuki T, Agishi T. Malignant tumors in dialysis patients:a nationwide survey. Proc Eur Dial Transplant Assoc 1981; 18: 724-30.
10. Bush A, Gabriel R. Cancer in uremic patients. Clin Nephrol 1984; 22: 77-81.
11. Curtis JR. Cancer and patients with end-stage renal failure. Br Med J 1982; 284: 69-70.
12. Schollmeyer P, Bozkurt F. The immune system of the uremic patient: hemodialysis vs CAPD. Clin Nephrol 1988; 30 (Suppl): S37-40.
13. Bonomini M, Forster S, De Risio F, Rychly J, Nebe B, Manfrini V, Klinkmann H, Albertazzi A. Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis. Nephrol Dial Transplant 1995; 10: 1654-61.
14. Fabrizi F, Marcelli D, Bacchini G, Guarnori I, Erba G, Locatelli F. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease. Nephrol Dial Transplant 1994; 9: 780-4.
15. Yanagisawa H, Manabe S, Kanai Y, Wada O. Carcinogenic glutamic acid pyrolysis product in the dialysate of uremic patients treated by continuous ambulatory peritoneal dialysis. Clin Nephrol 1988; 30: 73-8.
16. Akizawa T, Kinugasa E, Koshikawa S. Increased risk of malignancy and blood-membrane interactions in uraemic patients. Nephrol Dial Transplant 1994; 9 (Suppl 2): S162-4.
17. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93-9.
18. Cuckovic C, Djukanovic L, Jankovic S, Stanojcic A, Dragicevic P, Radmilovic A, Lambic L, Stojanovic M, Milic M, Bakovic J, Radovic M, Labudovic M. Malignant tumors in hemodialysis patients. Nephron 1996; 73: 710-2.
19. Marple JT, MacDougall M. Development of malignancy in the endstage renal disease patient. Semin Nephrol 1993; 13: 306-14.
20. Shin MH, Oh HK, Ahn YO. Ten year trend of cancer incidence in Seoul, Korea: 1993-2002. J Prev Med Public Health 2008; 41: 92-9.
21. Kjellstrand CM. Are malignancies increased in uraemia? Nephron 1979; 23: 159-61.
22. Cengiz K, Block AM, Hossfeld DK, Anthone R, Anthone S, Sandberg AA. Sister chromatid exchange and chromosome abnormalities in uremic patients. Cancer Genet Cytogenet 1988; 36: 55-67.
23. De Sala O'shea E, Morey Molina A, Ferrutxe Frau J, Gutierrez Sanz- Gadea C, Alarcon Zurita A, Ozonas Moragues M. Cancer of the bladder and hemodialysis. Arch Esp Urol 1990; 43: 359-63.
24. Ishikawa I. Renal cell carcinoma in chronic hemodialysis patients-a 1990 questionnaire study in Japan. Kidney Int 1993; 41 (Suppl): S167-9.
25. Inamoto H, Ozaki R, Matsuzaki T, Wakui M, Saruta T, Osawa A. Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients. Nephron 1991; 59: 611-7.
26. Agraharkar ML, Cinclair RD, Kuo YF, Daller JA, Shahinian VB. Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kindey Int 2004; 66: 383-9.
27. Morath C, Mueller M, Goldschmidt H, Schwenger V, Opelz G, Zeier M. Malignancy in renal transplantation. J Am Soc Nephrol 2004; 15: 1582-8.
28. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-13.
29. Niu MT, Coleman PJ, Alter MJ. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis 1993; 22: 568-73.
30. Basi S, Schulman G, Fogo AB. Multiple complications in multiple myeloma. Am J Kidney Dis 2005; 45: 619-23.
31. Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 1996; 17: 45-63.
32. Vamvakas S, Bahner U, Heidland A. Cancer in end-stage renal disease: potential factors involved. Am J Nephrol 1998; 18: 89-95.
33. Klyachkin ML, Sloan DA. Secondary hyperparathyroidism: evidence for an association with papillary thyroid cancer. Am Surg 2001; 67: 397-9.